Valuation: Zimmer Biomet Holdings, Inc.

Capitalization 18.23B 15.73B 14.79B 13.41B 24.73B 1,567B 27.9B 172B 67.21B 718B 68.41B 66.97B 2,627B P/E ratio 2025 *
19.5x
P/E ratio 2026 * 17.4x
Enterprise value 23.51B 20.28B 19.06B 17.29B 31.88B 2,020B 35.97B 222B 86.65B 925B 88.19B 86.33B 3,387B EV / Sales 2025 *
2.87x
EV / Sales 2026 * 2.67x
Free-Float
62.74%
Yield 2025 *
1.06%
Yield 2026 * 1.11%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.59%
1 week-1.32%
Current month-0.61%
1 month-5.51%
3 months-18.06%
6 months-14.27%
Current year-13.28%
More quotes
1 week 90.36
Extreme 90.36
95.35
1 month 89.22
Extreme 89.22
96.26
Current year 89.22
Extreme 89.22
114.44
1 year 89.22
Extreme 89.22
116.71
3 years 89.22
Extreme 89.22
149.25
5 years 89.22
Extreme 89.22
180.36
10 years 74.37
Extreme 74.37
180.36
More quotes
Manager TitleAgeSince
Chief Executive Officer 48 21/08/2023
Director of Finance/CFO 56 30/06/2019
Chief Tech/Sci/R&D Officer - 06/06/2021
Director TitleAgeSince
Director/Board Member 69 11/02/2007
Director/Board Member 68 12/03/2008
Director/Board Member 69 31/12/2008
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.59%-1.32%-14.41%-11.27% 18.23B
-0.43%+0.11%+29.10%+30.84% 233B
-1.27%-0.67%+8.64%-0.62% 113B
+0.65%+3.99%+25.81%+109.48% 56.69B
-0.69%-0.75%-26.44%-27.06% 49.33B
+0.55%-0.84%-8.35%+33.58% 39.2B
-0.41%-3.50%-29.05%+21.61% 32.54B
-0.31%-0.90%+0.54%+34.64% 26.58B
-1.26%-1.76%+10.32%+22.22% 23.72B
-3.23%+1.91%+15.00%-31.72% 23.05B
Average -0.70%+0.18%+1.12%+18.17% 61.52B
Weighted average by Cap. -0.59%+0.35%+11.36%+23.61%
See all sector performances

Financials

2025 *2026 *
Net sales 8.18B 7.06B 6.63B 6.01B 11.09B 703B 12.51B 77.34B 30.14B 322B 30.68B 30.03B 1,178B 8.62B 7.44B 6.99B 6.34B 11.69B 741B 13.2B 81.56B 31.79B 339B 32.36B 31.67B 1,243B
Net income 917M 791M 744M 674M 1.24B 78.79B 1.4B 8.67B 3.38B 36.09B 3.44B 3.37B 132B 1B 866M 814M 738M 1.36B 86.22B 1.54B 9.49B 3.7B 39.5B 3.77B 3.69B 145B
Net Debt 5.27B 4.55B 4.28B 3.88B 7.15B 453B 8.07B 49.87B 19.44B 208B 19.78B 19.37B 760B 4.77B 4.12B 3.87B 3.51B 6.47B 410B 7.31B 45.16B 17.6B 188B 17.91B 17.54B 688B
More financial data * Estimated data
Logo Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (67.7%): knees replacement (60.7% of net sales), hips replacement (39.3%); - surgical products and traumatology equipment (23.7%); - other (8.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2023, the group had approximately 25 production sites worldwide. Net sales are distributed geographically as follows: Americas (62.5%), Europe/Middle East/Africa (21.6%) and Asia/Pacific (15.9%).
Employees
17,000
Calendar
More about the company
Date Price Change Volume
17/06/25 90.21 $ -2.12% 1,629,298
16/06/25 92.16 $ +0.96% 2,206,440
13/06/25 91.28 $ -2.12% 1,370,501
12/06/25 93.26 $ -1.04% 1,110,842
11/06/25 94.24 $ -0.72% 1,217,541

Delayed Quote Nyse, June 17, 2025 at 04:42 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
92.16USD
Average target price
107.50USD
Spread / Average Target
+16.64%
Consensus

Quarterly revenue - Rate of surprise